Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Circulation|March 13, 2002
Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?R John Simes, Ian C Marschner, David Hunt, et al.
American Heart Journal|September 25, 2004
Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndromeHassan Kassem-Moussa, Kenneth W Mahaffey, Carmelo Graffagnino, et al.
Circulation|April 6, 2005
White blood cell count predicts reduction in coronary heart disease mortality with pravastatinRalph A H Stewart, Harvey D White, Adrienne C Kirby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Adjuvant immunotherapy of patients with high-risk melanoma using vaccinia viral lysates of melanoma: results of a randomized trialPeter Hersey, Alan S Coates, William H McCarthy, et al.
The American Journal of Cardiology|March 28, 2006
Frequency of recurrent ST-elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaquesJohn J Edmond, John K French, Ralph A H Stewart, et al.
The Medical Journal of Australia|October 17, 2002
Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?Paul P Glasziou, Simon D Eckermann, Sarah E Mulray, et al.
American Heart Journal|March 12, 2011
High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaborationSanneke P M de Boer, Elizabeth H Barnes, Cynthia M Westerhout, et al.
Breast Cancer Research and Treatment|October 18, 2008
Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial)Michaella J Smith, P Grantley Gill, Neil Wetzig, et al.
Diabetes Care|January 3, 2012
Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD StudyRu-Dee Ting, Anthony C Keech, Paul L Drury, et al.
The Lancet. Oncology|September 1, 2005
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trialBryan H Burmeister, B Mark Smithers, Val Gebski, et al.
Pageof 8